Fenwick & West LLP represented DexCare,Inc. in the transaction. DexCare, Inc. announced the close of its $75 million Series C funding round led by ICONIQ Growth...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP is representing Cisco in the transaction. Fenwick is representing CISCO Systems, Inc. (NASDAQ: CSCO), announced its pending acquisition of Accedian, a network...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented Mozart Therapeutics on the deal. Mozart Therapeutics, a leading developer of CD8 Treg Modulators for the treatment of autoimmune and inflammatory...
You must be a Standard 1 Year member to access this content.
Paul Hastings represented Spearmint as borrower and its subsidiaries as guarantors. Holland and Knight served as legal counsel for Aiga. Spearmint Energy announced the close of a...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented Define Ventures in the deal. Define Ventures, an early-stage venture firm focused on investing in digital health companies that are redefining...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented Armorblox in the transaction. Cisco Systems, Inc. (NASDAQ: CSCO), a worldwide leader in technology, announced its pending acquisition of Armorblox, a cybersecurity...
You must be a Standard 1 Year member to access this content.
Fenwick represented Coinbase Global, Inc. on the deal. Coinbase Global, Inc. (Nasdaq: COIN), a leading provider of end-to-end financial infrastructure and technology for the cryptoeconomy, announced...
You must be a Standard 1 Year member to access this content.
Fenwick represented Day One Biopharmaceuticals, Inc. on the offering, while Cooley LLP represented the underwriters. Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a clinical-stage biopharmaceutical company focused...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented Chinook Therapeutics, Inc. on the transaction, while Hogan Lovells US LLP represented Novartis AG. Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company, announced...
You must be a Standard 1 Year member to access this content.
Fenwick represented Shift5 on the deal. Shift5, the onboard data company, announced it has raised $33 million in additional financing, bringing its Series B round to...
You must be a Standard 1 Year member to access this content.
Fenwick represented Griffin Gaming Partners on the deal. HyperPlay, a Web3-native game launcher and aggregator of multiple game stores, announced a $12 million in Series A...
You must be a Standard 1 Year member to access this content.
